JNJ

190.67

-0.69%↓

ABT

126.65

+0.42%↑

MDT

93.71

-0.66%↓

VEEV

294.02

+1.11%↑

A

147.88

+0.4%↑

JNJ

190.67

-0.69%↓

ABT

126.65

+0.42%↑

MDT

93.71

-0.66%↓

VEEV

294.02

+1.11%↑

A

147.88

+0.4%↑

JNJ

190.67

-0.69%↓

ABT

126.65

+0.42%↑

MDT

93.71

-0.66%↓

VEEV

294.02

+1.11%↑

A

147.88

+0.4%↑

JNJ

190.67

-0.69%↓

ABT

126.65

+0.42%↑

MDT

93.71

-0.66%↓

VEEV

294.02

+1.11%↑

A

147.88

+0.4%↑

JNJ

190.67

-0.69%↓

ABT

126.65

+0.42%↑

MDT

93.71

-0.66%↓

VEEV

294.02

+1.11%↑

A

147.88

+0.4%↑

Search

Actinium Pharmaceuticals Inc

Deschisă

1.69 19.86

Rezumat

Modificarea prețului

24h

Curent

Minim

1.3900000000000001

Maxim

1.69

Indicatori cheie

By Trading Economics

Venit

9.1M

-6.9M

Marjă de profit

-821.235

Angajați

27

EBITDA

9.1M

-7.5M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+212.5% upside

Dividende

By Dow Jones

Următoarele câștiguri

12 nov. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-4.4M

47M

Deschiderea anterioară

-18.17

Închiderea anterioară

1.69

Actinium Pharmaceuticals Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 oct. 2025, 20:49 UTC

Câștiguri

Correction to Thermo Fisher Article on Oct. 22

23 oct. 2025, 23:51 UTC

Market Talk

WiseTech Bull Cheered by DSV's Freight Volumes -- Market Talk

23 oct. 2025, 23:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 oct. 2025, 23:49 UTC

Market Talk

Nikkei May Rise on Hopes for Easing U.S.-China Tensions -- Market Talk

23 oct. 2025, 23:37 UTC

Market Talk

Gold Falls on Likely Further Unwinding of Long Positions -- Market Talk

23 oct. 2025, 22:58 UTC

Market Talk

Global Energy Roundup: Market Talk

23 oct. 2025, 22:57 UTC

Market Talk

Woodside's Deal With Williams Eases Risks on Louisiana LNG Project -- Market Talk

23 oct. 2025, 22:49 UTC

Achiziții, Fuziuni, Preluări

How Trump Sparked a New Era of State Capitalism -2-

23 oct. 2025, 22:49 UTC

Achiziții, Fuziuni, Preluări

How Trump Sparked a New Era of State Capitalism -- Barrons.com

23 oct. 2025, 22:17 UTC

Câștiguri

Intel Shows Progress in First Earnings Report Since U.S. Investment -- 3rd Update

23 oct. 2025, 21:41 UTC

Câștiguri

Intel Shows Progress in First Earnings Report Since U.S. Investment -- 2nd Update

23 oct. 2025, 21:05 UTC

Câștiguri

Valero Earnings Show Why Refiners Are Energy's Big Winners This Year -- Barrons.com

23 oct. 2025, 20:50 UTC

Market Talk
Câștiguri

Tech, Media & Telecom Roundup: Market Talk

23 oct. 2025, 20:50 UTC

Market Talk
Câștiguri

Auto & Transport Roundup: Market Talk

23 oct. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23 oct. 2025, 20:35 UTC

Câștiguri

These Stocks Moved the Most Today: Tesla, IBM, D-Wave Quantum, Dow Inc., Molina Healthcare, Las Vegas Sands, Southwest, and More -- Barrons.com

23 oct. 2025, 20:28 UTC

Câștiguri

Intel Shows Progress in First Earnings Report Since U.S. Investment -- Update

23 oct. 2025, 20:15 UTC

Market Talk
Câștiguri

Global Commodities Roundup: Market Talk

23 oct. 2025, 20:10 UTC

Câștiguri

Newmont Mining 3Q Adj EPS $1.71

23 oct. 2025, 20:10 UTC

Câștiguri

Newmont Mining 3Q Sales $5.52B

23 oct. 2025, 20:10 UTC

Câștiguri

Newmont Mining 3Q EPS $1.67

23 oct. 2025, 20:09 UTC

Câștiguri

Intel Stock Rises After Strong Earnings. CFO Says Chip Demand Will Outpace Supply Into Next Year. -- Barrons.com

23 oct. 2025, 20:07 UTC

Market Talk
Câștiguri

Global Equities Roundup: Market Talk

23 oct. 2025, 20:07 UTC

Market Talk
Câștiguri

Ford Scrambles to Mitigate New Costs from Supplier Fire -- Market Talk

23 oct. 2025, 20:07 UTC

Câștiguri

Blackstone Looks to IPOs for Investment Exits -- Update

23 oct. 2025, 20:05 UTC

Câștiguri

Intel 3Q Gross Margin 38.2% >INTC

23 oct. 2025, 20:04 UTC

Câștiguri

Intel CFO: 'Current Demand Is Outpacing Supply, a Trend We Expect Will Persist Into 2026' >INTC

23 oct. 2025, 20:04 UTC

Câștiguri

Intel Shows Progress in First Earnings Report Since U.S. Investment -- WSJ

23 oct. 2025, 20:04 UTC

Câștiguri

Intel: 4Q Guidance Excludes Altera >INTC

23 oct. 2025, 20:04 UTC

Câștiguri

Intel Sees 4Q Adj EPS 8c >INTC

Comparație

Modificare preț

Actinium Pharmaceuticals Inc Așteptări

Obiectiv de preț

By TipRanks

212.5% sus

Prognoză pe 12 luni

Medie 4.5 USD  212.5%

Maxim 5 USD

Minim 4 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruActinium Pharmaceuticals Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

2

Cumpărare

0

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.
help-icon Live chat